ReviewInternational journal of molecular sciences2026
Operon™ Platform-Enabled for Cardiometabolic Biomarker Screening and Precision Treatment Strategies: A Type 2 Diabetes-Centered Review with Cardiovascular Extension.
Ian Jenkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.